Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Taduru Sreenath

The Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclastogenic Pathway Is Elevated in Amelogenin-Null Mice

Journal of Biological Chemistry

English

Related publications

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Protects Against Hepatic Ischemia/Reperfusion Injury in Mice

English

Osteoprotegerin, Receptor Activator of Nuclear Factor kB and Receptor Activator of Nuclear Factor κB Ligand and Bone Mineralization in Children With Inflammatory Bowel Diseases

Przeglad Gastroenterologiczny

Gastroenterology

2011

English

The Relationship Between Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Gene Polymorphism and Aortic Calcification in Korean Women

English

Increased Breast Tissue Receptor Activator of Nuclear Factor- κB Ligand (RANKL) Gene Expression Is Associated With Higher Mammographic Density in Premenopausal Women

Oncotarget

Oncology

2017

English

Activation of Liver X Receptor (LXR) Inhibits Receptor Activator of Nuclear Factor κB Ligand (RANKL)-induced Osteoclast Differentiation in an LXRβ-dependent Mechanism

Journal of Biological Chemistry

English

Mycobacterium Tuberculosis 10-kDa Co-Chaperonin Regulates the Expression Levels of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in Human Osteoblasts

Experimental and Therapeutic Medicine

English

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Directly Modulates the Gene Expression Profile of RANK-positive Saos-2 Human Osteosarcoma Cells

English

Role of Nuclear Factor κB in Ovarian Hormone-Mediated Stress Hypersensitivity in Female Mice

Biological Psychiatry

2009

English

The Lymphotoxin-Β Receptor Is an Upstream Activator of NF-κB-mediated Transcription in Melanoma Cells

Journal of Biological Chemistry

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Taduru Sreenath

The Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclastogenic Pathway Is Elevated in Amelogenin-Null Mice

Related publications

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Protects Against Hepatic Ischemia/Reperfusion Injury in Mice

Osteoprotegerin, Receptor Activator of Nuclear Factor kB and Receptor Activator of Nuclear Factor κB Ligand and Bone Mineralization in Children With Inflammatory Bowel Diseases

The Relationship Between Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Gene Polymorphism and Aortic Calcification in Korean Women

Increased Breast Tissue Receptor Activator of Nuclear Factor- κB Ligand (RANKL) Gene Expression Is Associated With Higher Mammographic Density in Premenopausal Women

Activation of Liver X Receptor (LXR) Inhibits Receptor Activator of Nuclear Factor κB Ligand (RANKL)-induced Osteoclast Differentiation in an LXRβ-dependent Mechanism

Mycobacterium Tuberculosis 10-kDa Co-Chaperonin Regulates the Expression Levels of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in Human Osteoblasts

Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Directly Modulates the Gene Expression Profile of RANK-positive Saos-2 Human Osteosarcoma Cells

Role of Nuclear Factor κB in Ovarian Hormone-Mediated Stress Hypersensitivity in Female Mice

The Lymphotoxin-Β Receptor Is an Upstream Activator of NF-κB-mediated Transcription in Melanoma Cells